The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing

The Lead

Amgen Laying Off at Least 2,400

July 30, 2014 | by LINDA A. JOHNSON, AP Business Writer | News | Comments

Amgen said it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations.           

View Sample

FREE Daily Email Newsletter

Probe Exposes Flaws Behind Rollout

July 30, 2014 4:03 pm | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

Management failures by the Obama administration set the stage for the computer woes that paralyzed the president's new health care program last fall, nonpartisan investigators said in testimony released Wednesday.      


Illinois Medicaid Restricts Use of Hepatitis Drug

July 30, 2014 3:57 pm | by CARLA K. JOHNSON, AP Medical Writer | News | Comments

Facing ballooning costs for a $1,000 pill to treat hepatitis C, Illinois' Medicaid program is putting tight restrictions in place, including requiring patients to meet 25 criteria and get prior approval before the government program will pay for the new drug.


Pharma Economics - 101

July 30, 2014 3:22 pm | by Mike Auerbach, Editor In Chief | Blogs | Comments

There has always been much hand-wringing and shouting regarding the costs of new medications. Most of this comes from people outside the industry – politicians, public health advocates, and a smattering of those that just like to hear themselves talk.


Ready-To-Use Filtration Unit

July 30, 2014 11:08 am | by Nikita Ernst, Associate Editor | EMD Millipore Corporation | Product Releases | Comments

Introducing the EZ-Fit™ Filtration Unit, a ready-to-use, disposable filtration device for bioburden testing.

McKesson Extends Pharmaceutical Distribution Agreement with CVS Caremark

July 30, 2014 10:45 am | News | Comments

McKesson Corporation today announced a three-year extension of its existing distribution agreement with CVS Caremark through June, 2019.                   


AstraZeneca and Kyowa Hakko Kirin Partner on Immuno-Oncology Clinical Study

July 30, 2014 10:02 am | News | Comments

AstraZeneca today announced that it has entered into a clinical study collaboration with Kyowa Hakko Kirin for a Phase I/Ib immuno-oncology study that will evaluate the safety and efficacy of two separate combinations of three investigational compounds in multiple solid tumours.


Can Cancer Research Be Fast-Tracked?

July 30, 2014 8:53 am | Videos | Comments

The Multiple Myeloma Research Foundation encourages research centers to give their data free to anyone that wants it, which can lead to faster trials and drug development.             

PCI Announces Definitive Agreement to Acquire Penn Pharma

July 30, 2014 8:38 am | News | Comments

Packaging Coordinators has reached a definitive agreement to acquire Penn Pharmaceutical Services Limited. Penn Pharma is headquartered in Tredegar, Wales in the United Kingdom and operates regional offices in New Hope, Pennsylvania and Tokyo, Japan.


Top Doctor Dies from Ebola after Treating Dozens

July 30, 2014 8:20 am | by CLARENCE ROY-MACAULAY, Associated Press; KRISTA LARSON, Associated Press | News | Comments

A leading doctor who risked his own life to treat dozens of Ebola patients died Tuesday from the disease, officials said, as a major regional airline announced it was suspending flights to the cities hardest hit by an outbreak that has killed more than 670 people.


Tuberculosis Patient Who Refused Care is Arrested

July 30, 2014 8:14 am | by SCOTT SMITH, Associated Press | News | Comments

A California man who disappeared after refusing treatment for tuberculosis, which can be contagious and spreads by coughing or sneezing, was found and arrested on charges of refusing to comply with health officials.      


FDA Approves EYLEA Injection for the Treatment of Diabetic Macular Edema

July 30, 2014 8:03 am | News | Comments

Regeneron Pharmaceuticals announced that the FDA has approved EYLEA Injection for the treatment of Diabetic Macular Edema (DME). The recommended dosage of EYLEA in patients with DME is 2 milligrams every two months after five initial monthly injections.


Impax Labs Shares Slump after FDA Inspection

July 29, 2014 3:59 pm | News | Comments

Shares of Impax Labs sank Tuesday after an FDA inspection uncovered potential problems at a facility where the company will make its experimental Parkinson's disease drug Rytary.            


Generation of Tanners See Spike in Deadly Melanoma

July 29, 2014 3:53 pm | by ANNE FLAHERTY, Associated Press | News | Comments

Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.          


ISPE Hires Healthcare Association Exec as CEO

July 29, 2014 3:47 pm | News | Comments

ISPE has hired John Bournas as President and CEO, succeeding Nancy Berg who announced plans to leave the Society last fall. Mr. Bournas takes the helm at ISPE with extensive competencies in the healthcare association industry as well as significant international experience.


Fitch: Biologics Driving Revenue Gains for U.S. Pharmaceutical Companies

July 29, 2014 3:39 pm | News | Comments

Fitch Ratings expects that revenues from biologic therapies as a percentage of total pharmaceutical sales will continue to increase over the intermediate term as companies increase their prominence in their drug portfolios, according to a report published today.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.